Page last updated: 2024-10-26

doxapram and Vomiting

doxapram has been researched along with Vomiting in 1 studies

Doxapram: A central respiratory stimulant with a brief duration of action. (From Martindale, The Extra Pharmocopoeia, 30th ed, p1225)
doxapram : A member of the class of pyrrolidin-2-ones that is N-ethylpyrrolidin-2-one in which both of the hydrogens at the 3 position (adjacent to the carbonyl group) are substituted by phenyl groups, and one of the hydrogens at the 4 position is substituted by a 2-(morpholin-4-yl)ethyl group. A central and respiratory stimulant with a brief duration of action, it is used (generally as the hydrochloride or the hydrochloride hydrate) as a temporary treatment of acute respiratory failure, particularly when superimposed on chronic obstructive pulmonary disease, and of postoperative respiratory depression. It has also been used for treatment of postoperative shivering.

Vomiting: The forcible expulsion of the contents of the STOMACH through the MOUTH.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Björk, L1
Arborelius, M1
Renck, H1
Rosberg, B1

Trials

1 trial available for doxapram and Vomiting

ArticleYear
Doxapram improves pulmonary function after upper abdominal surgery.
    Acta anaesthesiologica Scandinavica, 1993, Volume: 37, Issue:2

    Topics: Abdomen; Blood Pressure; Carbon Dioxide; Cholecystectomy; Doxapram; Female; Functional Residual Capa

1993